Zobrazeno 1 - 10
of 408
pro vyhledávání: '"leucèmia"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Xavier Calvo, David Roman-Bravo, Nieves Garcia-Gisbert, Juan Jose Rodriguez-Sevilla, Sara Garcia-Avila, Lourdes Florensa, Joan Gibert, Concepción Fernández-Rodríguez, Marta Salido, Anna Puiggros, Blanca Espinet, Luis Colomo, Beatriz Bellosillo, Ana Ferrer, Leonor Arenillas
Publikováno v:
Blood Advances. 6:3921-3931
Patients with oligomonocytic chronic myelomonocytic leukemia (OM-CMML) are currently classified according to the 2017 World Health Organization myelodysplastic syndromes classification. However, recent data support considering OM-CMML as a specific s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9a5b7ecd477be138789ef9e8757de0b
https://doi.org/10.1182/bloodadvances.2022007359
https://doi.org/10.1182/bloodadvances.2022007359
Publikováno v:
Stem Cells Translational Medicine. 11:1123-1134
Several decades have passed since the generation of the first embryonic stem cell (ESC) lines both in mice and in humans. Since then, stem cell biologists have tried to understand their potential biological and clinical uses for their implementation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b41cc5492dd82db64893531a1ad4bcc
https://doi.org/10.1093/stcltm/szac071
https://doi.org/10.1093/stcltm/szac071
Autor:
Lucía Pérez-Lamas, Alejandro Luna, Concepción Boque, Blanca Xicoy, Pilar Giraldo, Raúl Pérez López, Concepción Ruiz Nuño, Natalia De las Heras, Elvira Mora Casterá, Javier López Marín, Adrián Segura Díaz, Valle Gómez, Patricia Vélez Tenza, Magdalena Sierra Pacho, Juan Antonio Vera Goñi, Melania Moreno Vega, Alberto Alvarez-Larrán, Montse Cortés, Manuel Pérez Encinas, Patricia Carrascosa Mastell, Anna Angona, Ana Rosell, Sunil Lakhwani, Mercedes Colorado, Elena Ramila, Carlos Cervero, Beatriz Cuevas, Lucía Villalón Blanco, Raquel de Paz, Antonio Paz Coll, María José Fernández, Luis Felipe Casado, Juan Manuel Alonso-Domínguez, María Magdalena Anguita Arance, Araceli Salamanca Cuenca, Antonio Jiménez-Velasco, Santiago Osorio Prendes, Marta Santaliestra, María José Lis Chulvi, Juan Carlos Hernández-Boluda, Valentín García-Gutiérrez
Publikováno v:
Scientia
Cancers
Volume 15
Issue 4
Pages: 1045
Cancers
Volume 15
Issue 4
Pages: 1045
Simple Summary After the recent irruption of asciminib into the therapeutic arsenal for chronic myeloid leukemia, real-life data remain scarce to determine which patients may benefit most from this drug. Data on the efficacy of the drug in real-world
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95d62a6253d555f83c73979b06dacbda
https://hdl.handle.net/11351/9705
https://hdl.handle.net/11351/9705
Autor:
Luca Vinci, Christian Flotho, Peter Noellke, Dirk Lebrecht, Riccardo Masetti, Valerie de Haas, Barbara De Moerloose, Michael Dworzak, Henrik Hasle, Tayfun Güngör, Jan Starý, Dominik Turkiewicz, Marek Ussowicz, Cristina Diaz de Heredia, Jochen Buechner, Kirsi Jahnukainen, Krisztian Kallay, Ivana Bodova, Owen P. Smith, Marco Zecca, Dorine Bresters, Peter Lang, Tania Nicole Masmas, Roland Meisel, Herbert Pichler, Miriam Erlacher, Gudrun Göhring, Franco Locatelli, Brigitte Strahm, Charlotte M. Niemeyer, Ayami Yoshimi
Publikováno v:
Scientia
Vinci, L, Flotho, C, Noellke, P, Lebrecht, D, Masetti, R, de Haas, V, De Moerloose, B, Dworzak, M, Hasle, H, Güngör, T, Starý, J, Turkiewicz, D, Ussowicz, M, de Heredia, C D, Buechner, J, Jahnukainen, K, Kallay, K, Bodova, I, Smith, O P, Zecca, M, Bresters, D, Lang, P, Masmas, T N, Meisel, R, Pichler, H, Erlacher, M, Göhring, G, Locatelli, F, Strahm, B, Niemeyer, C M & Yoshimi, A 2023, ' Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft ', Bone Marrow Transplantation, vol. 58, no. 5, pp. 607-609 . https://doi.org/10.1038/s41409-023-01942-4
Vinci, L, Flotho, C, Noellke, P, Lebrecht, D, Masetti, R, de Haas, V, De Moerloose, B, Dworzak, M, Hasle, H, Güngör, T, Starý, J, Turkiewicz, D, Ussowicz, M, de Heredia, C D, Buechner, J, Jahnukainen, K, Kallay, K, Bodova, I, Smith, O P, Zecca, M, Bresters, D, Lang, P, Masmas, T N, Meisel, R, Pichler, H, Erlacher, M, Göhring, G, Locatelli, F, Strahm, B, Niemeyer, C M & Yoshimi, A 2023, ' Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft ', Bone Marrow Transplantation, vol. 58, no. 5, pp. 607-609 . https://doi.org/10.1038/s41409-023-01942-4
Myeloproliferative disease; Paediatrics Enfermedad mieloproliferativa; Pediatría Malaltia mieloproliferativa; Pediatria Open Access funding enabled and organized by Projekt DEAL.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e05658aa731f44e16c1b8bc70fa6417
https://doi.org/10.1038/s41409-023-01942-4
https://doi.org/10.1038/s41409-023-01942-4
Autor:
Lionel Adès, Larisa Girshova, Vadim A. Doronin, María Díez-Campelo, David Valcárcel, Suman Kambhampati, Nora-Athina Viniou, Dariusz Woszczyk, Raquel De Paz Arias, Argiris Symeonidis, Achilles Anagnostopoulos, Eduardo Ciliao Munhoz, Uwe Platzbecker, Valeria Santini, Robert J. Fram, Ying Yuan, Sharon Friedlander, Douglas V. Faller, Mikkael A. Sekeres
Publikováno v:
Scientia
Pevonedistat; Chronic myelomonocytic leukemia Pevonedistat; Leucemia mielomonocítica crónica Pevonedistat; Leucèmia mielomonocítica crònica PANTHER is a global, randomized phase 3 trial of pevonedistat+azacitidine (n = 227) vs azacitidine monoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8838e72608b49d5e2a82c322c09cf86
https://doi.org/10.1182/bloodadvances.2022007334
https://doi.org/10.1182/bloodadvances.2022007334
Autor:
Mesegué Medà, Montserrat
[cat] La leucèmia limfoblàstica aguda (LLA) és l’expansió clonal de cèl·lules malignes originades a partir de progenitors hematopoètics i és el càncer pediàtric més freqüent. La supervivència dels pacients pediàtrics afectes de LLA ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______963::edf08cca14d479c22f6499a7720a5ba9
http://hdl.handle.net/10803/688373
http://hdl.handle.net/10803/688373
Autor:
Núñez Amela, Yáiza
[cat] La leucèmia mieloide aguda (LMA) és un grup heterogeni de malalties hematològiques que s'originen a partir de la proliferació clonal excessiva de cèl·lules precursores mieloides. Actualment, malgrat que la majoria de pacients inicialment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______963::46e3bebca850a3e39ddc11d31143117b
http://hdl.handle.net/2445/197605
http://hdl.handle.net/2445/197605
Autor:
Romina Royo, Laura Magnano, Julio Delgado, Sara Ruiz-Gil, Josep Ll. Gelpí, Holger Heyn, Malcom A. Taylor, Tatjana Stankovic, Xose S. Puente, Ferran Nadeu, Elías Campo
Publikováno v:
Scopus
UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
The authors thank the Hematopathology Collection registered at the Biobank of Hospital Clínic—Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) as well as Sílvia Martín for the technical support. This study was supported by t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::019fd8e273ed1ba266a6e5c65b4106f7
http://hdl.handle.net/2445/200343
http://hdl.handle.net/2445/200343